Healthcare

Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025

  • ALL3201244
  • 293 Pages
  • May 2019
  • Healthcare
Download Sample    Get Discount   
 
The global vital organs support systems and medical bionics market size in 2017 is $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 10.9% from 2018 to 2025.

An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addition to the body. These artificial implants mimic the function of the lost or nonfunctional body part.

The vital organs support systems and medical bionics market is expected to exhibit significant growth during the forecast period due to rise in geriatric population, scarcity of donor organs, technological advancements in the artificial organ sector, and increase in R&D expenditure. In addition, rise in number of patients suffering from chronic diseases drives the market growth. However, high cost of artificial organs and stringent approval process are projected to impede growth of the vital organs support systems and medical bionics market. On the contrary, application of advanced biomaterials in artificial organs and lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.

The global vital organs support systems and medical bionics market is segmented based on product, end user, and region. Depending on product, the market is categorized into vital organs support systems and medical bionics. The vital organs support systems segment is further divided into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. Depending on end user, the market is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

 This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.

 An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

 A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.

 An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

• By Product

o Vital organs support systems

 Artificial Heart

 Artificial Kidney

 Artificial Pancreas

 Artificial Urinary Bladder

 Artificial Lungs

 Artificial Liver

o Medical Bionics

o Bionic Eye

o Ear Bionics

 Cochlear Implants

 Bone Anchored Hearing Systems

 Auditory Brainstem Implants

o Orthopedic Bionics

 Upper limb

 Lower limb

• Bionic Knee

• Bionic Feet

 Exoskeleton

 Electrical Bone Growth Stimulators

• Non-Invasive Bone Growth Stimulators

• Invasive Bone Growth Stimulators

o Cardiac Bionics

 Pacemaker

• Implantable Pacemaker

• External Pacemaker

 Ventricular Assist Device

• Left Ventricular Assist Device (LVAD)

• Right Ventricular Assist Device (RVAD)

• Biventricular Assist Device (BIVAD)

 Artificial Heart Valves

• Mechanical Heart Valves

• Tissue Heart Valves

o Neural Bionics

 Internal Neurostimulators

• Deep Brain Stimulators (DBS)

• Sacral Nerve Stimulators (SNS)

• Vagus Nerve Stimulators (VNS)

• Spinal Cord Stimulators (SCS)

• Other Neurostimulators

 External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))

• By End User

o Hospitals

o Ambulatory Surgical Centers

o Others

• By Region

o North America

• U.S.

• Canada

• Mexico

o Europe

• Germany

• France

• UK

• Italy

• Spain

• Rest of Europe

o Asia-Pacific

• Australia

• Japan

• India

• China

• South Korea

• Rest of Asia-Pacific

o LAMEA

• Brazil

• Saudi Arabia

• South Africa

• Rest of LAMEA

KEY MARKET PLAYERS

• Abiomed, Inc.

• Abbott Laboratories

• Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)

• Baxter International Inc.

• Boston Scientific Corporation

• Cochlear Ltd.

• Edwards Lifesciences Corporation

• Jarvik Heart, Inc.

• Medtronic Plc.

• Össur Americas, Inc.

• Second Sight Medical Products, Inc.

• SynCardia Systems LLC

The other players in the value chain include (profiles not included in the report):

• Getinge AB

• LivaNova PLC

• Fresenius Medical Care AG & Co. KGaA

• Heartware International Inc.

• BiVACOR

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

2.2. Key findings

2.2.1. Top impacting factors

2.2.2. Top investment pockets

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key Forces Shaping vital organs support systems and medical bionics Market

3.2.1. Moderate bargaining power of suppliers

3.2.2. Low threat of new entrants

3.2.3. Low threat of substitutes

3.2.4. Moderate intensity of rivalry

3.2.5. High bargaining power of buyers

3.3. Pricing Analysis

3.3.1. Pricing Analysis, By Region, 2018 & 2025

3.4. Value Chain Analysis

3.5. Impact of government regulations on global vital organs support systems and medical bionics market

3.6. Clinical Trials

3.7. Industry Pain point analysis

3.8. Case Studies

3.8.1. Case Study 01

3.9. Market dynamics

3.9.1. Drivers

3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population

3.9.1.2. Rise in number of patients suffering from chronic diseases

3.9.1.3. Technological advancements

3.9.2. Restraints

3.9.2.1. High cost of treatment

3.9.2.2. Stringent approval process

3.9.3. Opportunities

3.9.3.1. Lucrative opportunities in emerging economies

CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE

4.1. Overview

4.2. Market size and forecast

4.3. Vital organs support systems

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by type

4.3.2.1. Artificial Heart

4.3.2.1.1. Market size and forecast

4.3.2.2. Artificial Kidney

4.3.2.2.1. Market size and forecast

4.3.2.3. Artificial Pancreas

4.3.2.3.1. Market size and forecast

4.3.2.4. Artificial Urinary Bladder

4.3.2.4.1. Market size and forecast

4.3.2.5. Artificial Lungs

4.3.2.5.1. Market size and forecast

4.3.2.6. Artificial Liver

4.3.2.6.1. Market size and forecast

4.3.3. Market size and forecast, by region

4.3.4. Market analysis by country

4.4. Medical Bionics

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by type

4.4.2.1. Bionic Eye

4.4.2.1.1. Market size and forecast

4.4.2.2. Ear Bionics

4.4.2.2.1. Market size and forecast, by type

4.4.2.2.1.1.1. Cochlear Implants

4.4.2.2.1.1.1.1 Market size and forecast

4.4.2.2.1.1.2. Bone Anchored Hearing Systems

4.4.2.2.1.1.2.1. Market size and forecast

4.4.2.2.1.1.3. Auditory Brainstem Implants

4.4.2.2.1.1.3.1 Market size and forecast

4.4.2.3. Orthopedic Bionics

4.4.2.3.1. Market size and forecast, by type

4.4.2.3.1.1.1. Upper Limb

4.4.2.3.1.1.2. Market size and forecast

4.4.2.3.1.1.3. Lower Limb

4.4.2.3.1.1.4. Market size and forecast, by type

4.4.2.3.1.1.4.1. Bionic Knee

4.4.2.3.1.1.4.1.1. Market size and forecast

4.4.2.3.1.1.4.2. Bionic Feet

4.4.2.3.1.1.4.2.1. Market size and forecast

4.4.2.3.1.1.5. Exoskeleton

4.4.2.3.1.1.6. Market size and forecast

4.4.2.3.1.1.7. Electrical Bone Growth Stimulators

4.4.2.3.1.1.8. Market size and forecast, by type

4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators

4.4.2.3.1.1.8.1.1. Market size and forecast

4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators

4.4.2.3.1.1.8.2.1. Market size and forecast

4.4.2.4. Cardiac Bionics

4.4.2.4.1. Market size and forecast, by type

4.4.2.4.1.1.1. Pacemaker

4.4.2.4.1.1.1.1 Market size and forecast, by type

4.4.2.4.1.1.2. Implantable Pacemaker

4.4.2.4.1.1.2.1. Market size and forecast

4.4.2.4.1.1.3. External pacemaker

4.4.2.4.1.1.3.1 Market size and forecast

4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)

4.4.2.4.1.1.4. Market size and forecast, by type

4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)

4.4.2.4.1.1.4.1.1. Market size and forecast

4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)

4.4.2.4.1.1.4.2.1. Market size and forecast

4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)

4.4.2.4.1.1.4.3.1. Market size and forecast

4.4.2.4.1.1.5. Artificial Heart Valves

4.4.2.4.1.1.6. Market size and forecast, by type

4.4.2.4.1.1.6.1. Mechanical Heart Valves

4.4.2.4.1.1.6.1.1. Market size and forecast

4.4.2.4.1.1.6.2. Tissue Heart Valves

4.4.2.4.1.1.6.2.1. Market size and forecast

4.4.2.5. Neural Bionics

4.4.2.5.1. Market size and forecast, by type

4.4.2.5.1.1. Internal Neurostimulators

4.4.2.5.1.1.1. Market size and forecast, by type

4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)

4.4.2.5.1.1.1.1.1. Market size and forecast

4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)

4.4.2.5.1.1.1.2.1. Market size and forecast

4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)

4.4.2.5.1.1.1.3.1. Market size and forecast

4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)

4.4.2.5.1.1.1.4.1. Market size and forecast

4.4.2.5.1.1.1.5. Other Neurostimulators

4.4.2.5.1.1.1.5.1. Market size and forecast

4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))

4.4.2.5.1.2.1. Market size and forecast

4.4.3. Market size and forecast, by region

4.4.4. Market analysis by country

CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER

5.1. Overview

5.2. Market size and forecast

5.3. Hospitals

5.3.1. Market size and forecast, by region

5.3.2. Market analysis by country

5.4. Ambulatory surgical centers (ASCs)

5.4.1. Market size and forecast, by region

5.4.2. Market analysis by country

5.5. Others

5.5.1. Market size and forecast, by region

5.5.2. Market analysis by country

CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities

6.2.2. North America vital organs support systems and medical bionics market, by country

6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type

6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user

6.2.2.3. Canada vital organs support systems and medical bionics market, by product type

6.2.2.4. Canada vital organs support systems and medical bionics market, by end user

6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type

6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user

6.2.3. North America vital organs support systems and medical bionics market, by product type

6.2.5. North America vital organs support systems and medical bionics market, by end user

6.3. Europe

6.3.1. Key market trends and opportunities

6.3.2. Europe vital organs support systems and medical bionics market, by country

6.3.2.1. Germany vital organs support systems and medical bionics market, by product type

6.3.2.3. Germany vital organs support systems and medical bionics market, by end user

6.3.2.4. France vital organs support systems and medical bionics market, by product type

6.3.2.6. France vital organs support systems and medical bionics market, by end user

6.3.2.7. Spain vital organs support systems and medical bionics market, by product type

6.3.2.8. Spain vital organs support systems and medical bionics market, by end user

6.3.2.9. Italy vital organs support systems and medical bionics market, by product type

6.3.2.11. Italy vital organs support systems and medical bionics market, by end user

6.3.2.12. UK vital organs support systems and medical bionics market, by product type

6.3.2.13. UK vital organs support systems and medical bionics market, by end user

6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type

6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user

6.3.3. Europe vital organs support systems and medical bionics market, by product type

6.3.5. Europe vital organs support systems and medical bionics market, by end user

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities

6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country

6.4.2.1. Australia vital organs support systems and medical bionics market, by product type

6.4.2.2. Australia vital organs support systems and medical bionics market, by end user

6.4.2.3. Japan vital organs support systems and medical bionics market, by product type

6.4.2.4. Japan vital organs support systems and medical bionics market, by end user

6.4.2.5. India vital organs support systems and medical bionics market, by product type

6.4.2.6. India vital organs support systems and medical bionics market, by end user

6.4.2.7. China vital organs support systems and medical bionics market, by product type

6.4.2.8. China vital organs support systems and medical bionics market, by end user

6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type

6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user

6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type

6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user

6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type

6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user

6.5. LAMEA

6.5.1. Key market trends and opportunities

6.5.2. LAMEA vital organs support systems and medical bionics market, by country

6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type

6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user

6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type

6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user

6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type

6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user

6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type

6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user

6.5.3. LAMEA vital organs support systems and medical bionics market, by product type

6.5.5. LAMEA vital organs support systems and medical bionics market, by end user

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction

7.2. Market Share Analysis of Top Players, 2018 (%)

7.4. Top winning strategies

7.4.1. Top Winning Strategies, By Year, 2015-2019*

7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)

7.4.3. Top Winning Strategies, By Company, 2015-2019*

7.5. Product Mapping of Top 12 Player

CHAPTER 8: COMPANY PROFILES:

8.1. Abiomed, Inc.

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Product portfolio

8.1.4. Business performance

8.1.5. Key strategic moves and developments

8.2. Abbott Laboratories (St. Jude Medical)

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Operating business segments

8.2.4. Product portfolio

8.2.5. Business performance

8.2.6. Key strategic moves and developments

8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product portfolio

8.3.5. Business performance

8.4. Baxter International Inc.

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

8.5. Boston Scientific Corporation

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

8.6. Cochlear Ltd.

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

8.6.6. Key strategic moves and developments

8.7. Edwards Lifesciences Corporation

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

8.7.6. Key strategic moves and developments

8.8. Jarvik Heart, Inc.

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Product portfolio

8.8.4. Key strategic moves and developments

8.9. Medtronic Plc. (Covidien Ltd.)

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.6. Key strategic moves and developments

8.10. Össur Americas, Inc.

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance

8.10.6. Key strategic moves and developments

8.11. Second Sight Medical Products, Inc.

8.11.1. Company overview

8.11.2. Company snapshot

8.11.3. Product portfolio

8.11.4. Key strategic moves and developments

8.12. SynCardia Systems LLC

8.12.1. Company overview

8.12.2. Company snapshot

8.12.3. Product portfolio

LIST OF TABLES

TABLE 01. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)

TABLE 02. VITAL ORGANS SUPPORT SYSTEMS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 03. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR VITAL ORGANS SUPPORT SYSTEMS , BY REGION 2017–2025 ($MILLION)

TABLE 04. MEDICAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 05. EAR BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 06. ORTHOPEDIC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 07. LOWER LIMB MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 08. ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 09. CARDIAC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 10. PACEMAKER MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 11. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 12. ARTIFICIAL HEART VALVES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 13. NEURAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 14. INTERNAL NEUROSTIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)

TABLE 15. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR MEDICAL BIONICS, BY REGION 2017–2025 ($MILLION)

TABLE 16. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)

TABLE 17. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR HARDWARE, BY REGION 2017–2025($MILLION)

TABLE 18. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2017–2025($MILLION)

TABLE 19. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR OTHER END USERS, BY REGION, 2017–2025($MILLION)

TABLE 20. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 21. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 22. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 23. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 24. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 25. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 26. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 27. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 28. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 29. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 30. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 31. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 32. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 33. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 34. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 35. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 36. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 37. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 38. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 39. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 40. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 41. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 42. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 43. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 44. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 45. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 46. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 47. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 48. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 49. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 50. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 51. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 52. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 53. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 54. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 55. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 56. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 57. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 58. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 59. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 60. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 61. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 62. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 63. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 64. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 65. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 66. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 67. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 68. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 69. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)

TABLE 70. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)

TABLE 71. ABIOMED: COMPANY SNAPSHOT

TABLE 72. ABIOMED: PRODUCT PORTFOLIO

TABLE 73. ABBOTT: COMPANY SNAPSHOT

TABLE 74. ABBOTT: OPERATING SEGMENTS

TABLE 75. ABBOTT: PRODUCT PORTFOLIO

TABLE 76. ASAHI KASEI: COMPANY SNAPSHOT

TABLE 77. ASAHI KASEI: OPERATING SEGMENTS

TABLE 78. ASAHI KASEI: PRODUCT PORTFOLIO

TABLE 79. BAXTER: COMPANY SNAPSHOT

TABLE 80. BAXTER: OPERATING SEGMENTS

TABLE 81. BAXTER: PRODUCT PORTFOLIO

TABLE 82. BOSTON SCIENTIFIC: COMPANY SNAPSHOT

TABLE 83. BOSTON SCIENTIFIC: OPERATING SEGMENTS

TABLE 84. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 85. COCHLEAR: COMPANY SNAPSHOT

TABLE 86. COCHLEAR: OPERATING SEGMENTS

TABLE 87. COCHLEAR: PRODUCT PORTFOLIO

TABLE 88. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT

TABLE 89. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO

TABLE 90. JARVIK HEART: COMPANY SNAPSHOT

TABLE 91. JARVIK HEART: PRODUCT PORTFOLIO

TABLE 92. MEDTRONIC: COMPANY SNAPSHOT

TABLE 93. MEDTRONIC: OPERATING SEGMENTS

TABLE 94. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 95. ÖSSUR: COMPANY SNAPSHOT

TABLE 96. ÖSSUR: OPERATING SEGMENTS

TABLE 97. ÖSSUR: PRODUCT PORTFOLIO

TABLE 98. SECOND SIGHT: COMPANY SNAPSHOT

TABLE 99. SECOND SIGHT: PRODUCT PORTFOLIO

TABLE 100. SYNCARDIA: COMPANY SNAPSHOT

TABLE 101. SYNCARDIA: PRODUCT PORTFOLIO

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370